Resources

Past Presentation
Training

Providing Opioid Use Disorder Services in the Era of Fentanyl | July 26, 2024

Date of Presentation: July 26, 2024

In this series of presentations, Dr. Jessica Gregg, MD, PhD, and Dr. Jonathan Robbins, MD, MS, review the diagnostic criteria for substance use disorders, provide an overview of the neurobiology of addiction, and share ways to effectively integrate evidence-based clinical strategies to treat opioid use disorder in the of fentanyl.

Recording:

Presented by:

Dr. Jessica Gregg
Dr. Jessica Gregg
Lead Faculty

Jessica Gregg, MD, PhD, received her undergraduate degree at Stanford University, her medical degree at the University of New Mexico, and a PhD in Medical Anthropology at Emory University. She began her medical career in primary care at Oregon Health and Science University (OHSU), where she co-founded the OHSU Department of Medicine’s Social Medicine curriculum in partnership with City Central Concern, a non-profit caring for individuals struggling with lack of housing and substance use disorders. She subsequently became the medical director for Central City Concern’s Hooper Detoxification and Stabilization Center, and eventually assumed the role of Senior Medical Director for Substance Use Disorder Services for the agency. She subsequently developed the HRBR clinic at OHSU, a low-threshold buprenorphine clinic, and in 2021, she became Chief Medical Officer for Fora Health in Portland, Oregon.

Read the full bio …

Dr. Jonathan Leserman Robbins
Dr. Jonathan Leserman Robbins
Faculty

Jonathan Leserman Robbins, MD, MS, is a general internist and primary care doctor at Oregon Health & Science University in Portland, OR. He splits his time between outpatient primary care, the inpatient addiction consult service, and a pain and addiction consult clinic. He is an active educator and participates in several ECHOs on pain and addiction.

Read the full bio …

Resources Provided:

Date added: July 15, 2024